Enlivex Therapeutics Ltd. (ENLV) – Management Comments
-
Enlivex Therapeutics Ltd. (ENLV) Reports First Two Patients Dosing in Phase II Clinical Trial Evaluating Allocetra in Severe & Critical COVID-19 Patients
-
Enlivex Therapeutics Ltd. (ENLV) Announces Positive Allocetra Trial Results in COVID-19 Patients in Severe/Critical Condition
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ENLV Stock Lookup